Key result
Polycystic ovary syndrome is associated with increased cardiovascular risk factors, but it remains unclear whether there is an associated increase in cardiovascular events.
Why the study?
It remains unclear whether polycystic ovary syndrome is associated with an increased risk of cardiovascular events despite known increased prevalence of diabetes and cardiovascular risk factors.
Answers are grounded in this paper and cite their sources.
Cardiovascular risk in PCOS is likely driven by associated insulin resistance and obesity, highlighting the need for long-term outcome studies.
The polycystic ovary syndrome (PCOS) is a common endocrine disorder in women that is associated with an increased prevalence of type 2 diabetes and other cardiovascular risk factors. It remains unclear, however, whether there is an associated increase in cardiovascular events in this condition. Increased prevalence of non‐traditional risk factors, such as abnormalities of inflammation, coagulation, oxidative stress, arterial stiffness and endothelial dysfunction, has recently been reported in PCOS. Collectively, these studies have demonstrated biochemical, functional and structural abnormalities of the cardiovascular system. It seems that many of these cardiovascular abnormalities are related to the presence of insulin resistance and obesity rather than PCOS itself. Cohort studies of long‐term cardiovascular outcome in PCOS and clinical trials of risk factor modification in women with this condition are required.
No takes yet. Share an insight, caveat, or question.
Cussons et al. (2005) conducted a review in Polycystic ovary syndrome (PCOS). Polycystic ovary syndrome was evaluated. Polycystic ovary syndrome is associated with increased cardiovascular risk factors, but it remains unclear whether there is an associated increase in cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: